Athanase Innovation (ATIN) Q2 2026 earnings summary

Executive summary

• Net revenue for Q2 2026 was 1.8 MSEK, down from 5.4 MSEK in Q2 2025, entirely from IVISYS operations.

• Value change from securities was 8.1 MSEK, a significant improvement from -10.7 MSEK in Q2 2025.

• Operating result (EBIT) improved to -13.3 MSEK from -27.2 MSEK year-over-year.

• Sale of Zalaris shares generated 142 MSEK in proceeds and a realized gain of 51 MSEK.

• Board called an EGM to distribute all shares in subsidiary Palvora AB to shareholders.

Financial highlights

• Six-month net revenue was 3.9 MSEK (11.5 MSEK in 2025); value change from securities was 19.7 MSEK (-2.6 MSEK in 2025).

• Operating result for H1 2026 was -22.9 MSEK, improved from -36.4 MSEK in H1 2025.

• Cash flow for Q2 was 109.8 MSEK, ending cash at 347.5 MSEK (271.9 MSEK in 2025).

• Earnings per share for Q2 was -0.63 SEK (-1.35 SEK in 2025).

• Equity ratio at period end was 85.9% (89.6% in 2025).

Outlook and guidance

• Management maintains a long-term investment approach, focusing on factors within their control despite ongoing geopolitical and market volatility.

• Strategic restructuring aims to provide IVISYS with greater flexibility and growth opportunities as an independent entity.